Structure Therapeutics Inc. Experiences Stock Surge Amid GPCR Research Advances
Structure Therapeutics Inc. has seen a significant increase in its stock price, rising from a 52-week low of $13.22 to $25.33, driven by its focus on GPCR research and innovative therapeutics.
2 minutes to read